Vor bio to participate in the jmp securities hematology and oncology summit

Cambridge, mass., nov. 27, 2023 (globe newswire) -- vor bio (nasdaq: vor), a clinical-stage cell and genome engineering company, today announced that it will participate in a fireside chat and host virtual 1x1 investor meetings at the jmp securities hematology and oncology summit.
VOR Ratings Summary
VOR Quant Ranking